Acurx Pharmaceuticals (ACXP) Scheduled to Post Quarterly Earnings on Wednesday

Acurx Pharmaceuticals (NASDAQ:ACXP) is scheduled to be announcing its earnings results before the market opens on Wednesday, May 15th. Analysts expect the company to announce earnings of ($0.24) per share for the quarter. Persons interested in listening to the company’s earnings conference call can do so using this link.

Acurx Pharmaceuticals (NASDAQ:ACXP) last posted its earnings results on Friday, March 15th. The company reported ($0.38) earnings per share for the quarter, missing the consensus estimate of ($0.26) by ($0.12). On average, analysts expect Acurx Pharmaceuticals to post $-1 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Acurx Pharmaceuticals Stock Down 5.3 %

Shares of ACXP stock opened at $1.97 on Wednesday. The company’s fifty day simple moving average is $2.30 and its two-hundred day simple moving average is $3.26. Acurx Pharmaceuticals has a 52 week low of $1.17 and a 52 week high of $8.82. The stock has a market cap of $31.05 million, a P/E ratio of -1.77 and a beta of -1.79.

Analyst Ratings Changes

Separately, HC Wainwright decreased their target price on Acurx Pharmaceuticals from $14.00 to $12.00 and set a “buy” rating on the stock in a research report on Tuesday, March 19th.

Acurx Pharmaceuticals Company Profile

Acurx Pharmaceuticals, Inc, a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections.